Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.43 |
| ▸ | NPY2R | P49146 | 1/20 | 0.43 |
| ▸ | NPY4R | P50391 | 1/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6902989 | 1.00 | SLC6A2 (0.49) | SLC6A2CYP3A4CYP2C9HDAC8HDAC6 | |
| SCHEMBL5146562 | 0.98 | SLC6A2 (0.46) | SLC6A2CYP3A4CYP2C9HDAC8HDAC6 | |
| SCHEMBL5144848 | 0.93 | CNR2 (0.49) | SLC6A2CNR2SLC6A4SLC6A3TP53 | |
| SCHEMBL17858135 | 0.89 | EPHX1 (0.48) | SLC6A2CYP3A4CYP2C9HDAC8HDAC6 | |
| SCHEMBL628247 | 0.89 | TSHR (0.46) | SLC6A2CNR2ALDH1A1NPY1RNPY2R | |
| SCHEMBL20210326 | 0.88 | RAB9A (0.41) | SLC6A2CYP3A4CYP2C9HDAC8HDAC6 | |
| Tert-Butylbenzene SCHEMBL4814841 | 0.86 | SLC18A3 (0.49) | CYP2C9ALDH1A1TSHR | |
| SCHEMBL15317742 | 0.81 | HTR2C (0.59) | CNR2HTR2C | |
| SCHEMBL9842611 | 0.81 | RAB9A (0.43) | SLC6A2CYP3A4CYP2C9CNR2RAB9A | |
| SCHEMBL6275125 | 0.81 | HDAC8 (0.52) | HDAC8HDAC6HDAC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6503662-B1 | Tert-butylbenzene derivative prevents oxidation and decomposition of solvent at the time of charging which causes decreased battery characteristics | UBE INDUSTRIES, LTD. (JP) | 2003-01-07 | — | — | US | claimed |
| CN-1290974-A | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2001-04-11 | — | — | CN | claimed |
| CN-117229111-A | Dehydroaromatization method for aryl cyclic hydrocarbon | 五邑大学 | 2023-12-15 | — | — | CN | disclosed |
| US-9831525-B2 | Non-aqueous electrolyte secondary battery and method of fabricating same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2017-11-28 | — | — | US | disclosed |
| US-9780377-B2 | Non-aqueous electrolyte secondary battery and method for producing same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20150086851-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY AND METHOD FOR PRODUCING SAME OF FABRICATING SAME | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20150004448-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY AND METHOD FOR PRODUCING SAME | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2015-01-01 | — | — | US | disclosed |
| US-7566683-B2 | Ethylene derivatives and pesticides containing said derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-07-28 | — | — | US | disclosed |
| US-20070299072-A1 | KV1.5 POTASSIUM CHANNEL INHIBITORS | WYETH (US) | 2007-12-27 | — | — | US | disclosed |
| WO-2007100161-A1 | METHOD FOR PREFERENTIAL PRODUCTION OF GEOMETRIC ISOMERS AND ISOLATION METHOD | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-07 | — | — | WO | disclosed |
| CN-100336267-C | Non-aqeous electrolytic sotution and lithium accumulator using said non-aqeous electrolytic solution | UBE IND CORP (JP) | 2007-09-05 | — | — | CN | disclosed |
| CN-1190863-C | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2005-02-23 | — | — | CN | disclosed |
| US-20030216394-A1 | Etylene derivatives and pesticides containing said derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
| EP-1360901-A1 | 2,3-cyclic substituted derivatives of 3-hydroxyacrolein and 3-hydroxyacrylic acid as pesticides | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-0913392-B1 | ETHYLENE DERIVATIVES AND PEST CONTROLLING AGENTS | NISSAN CHEMICAL IND LTD (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-6462049-B1 | LOW TOXICITY AND PERSISTENT INSECTICIDES AND FUNGICIDES; PREVENTING ATTACHMENT OF AQUATIC ORGANISMS; ECOSYSTEM FRIENDLY; NONPOLLUTING | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-08 | — | — | US | disclosed |
| US-6399653-B1 | METABOLISM DIORDERS; CARDIOVASCULAR DISORDERS; NERVOUS SYSTEM DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 2002-06-04 | — | — | US | disclosed |
| CN-1290974-A | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2001-04-11 | — | — | CN | disclosed |
| US-6063734-A | AGRICULTURAL CHEMICALS, AGENTS FOR PREVENTING ATTACHMENT OF AQUATIC ORGANISMS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-05-16 | — | — | US | disclosed |
| EP-0913392-A1 | ETHYLENE DERIVATIVES AND PEST CONTROLLING AGENTS | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1999-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299072-A1 | KV1.5 POTASSIUM CHANNEL INHIBITORS | KCNA5, KCNH1, KCNK5 | SLC6A2 2171/4885CYP3A4 454/4885CYP2C9 635/4885 |
| US-20030216394-A1 | Etylene derivatives and pesticides containing said derivatives | DDT, ECE1, EBPL | SLC6A2 4396/4885CYP3A4 92/4885CYP2C9 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.